Cardiovascular · 2017

FDA-cleared AI devices for cardiovascular 2017

2017 has 7 cardiovascular AI devices, 75% more than 2016 (4). That is 4.5% of the 154 cardiovascular devices on the FDA list, and 25.9% of all AI-device decisions dated 2017. The most active were ImpediMed Limited (2), Cardiologs Technologies (1), Medtronic, Inc. (1). The newest is SOZO from ImpediMed Limited, decided on December 22, 2017.

72017 devices
6Companies
25.9%Of all 2017 AI devices
4.5%Of all cardiovascular

By month

Feb: 1Mar: 0Apr: 0May: 0Jun: 1Jul: 0Aug: 2Sep: 1Oct: 0Nov: 1Dec: 1
FebMarAprMayJunJulAugSepOctNovDec
Cardiovascular AI devices by month in 2017: Feb 1, Mar 0, Apr 0, May 0, Jun 1, Jul 0, Aug 2, Sep 1, Oct 0, Nov 1, Dec 1

All 7 devices

Frequently asked questions

How many FDA-cleared AI cardiovascular devices were there in 2017?

7 AI-enabled cardiovascular devices have a final decision dated 2017, from 6 companies.

How does 2017 compare with 2016 for AI cardiovascular devices?

2017 has 7 cardiovascular AI devices, 75% more than 2016 (4).

Which companies cleared the most AI cardiovascular devices in 2017?

ImpediMed Limited (2), Cardiologs Technologies (1), Medtronic, Inc. (1).

What was the most recent AI cardiovascular device in 2017?

SOZO from ImpediMed Limited (K172507), decided on December 22, 2017. Product code DSB.

Which product codes were most common for AI cardiovascular devices in 2017?

DPS (Electrocardiograph): 1; DPT (Probe, Blood-Flow, Extravascular): 1; DRG (Transmitters And Receivers, Physiological Signal, Radiofrequency): 1.

Cite as: AI Device Radar, “FDA-cleared AI devices for cardiovascular 2017,” https://ai-device-radar.vercel.app/specialty/cardiovascular/2017 (FDA list through 2026-06-29).